Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Circassia strikes deal with AstraZeneca for respiratory drugs

Britain’s Circassia has secured the U.S. rights from AstraZeneca for two drugs to treat chronic obstructive pulmonary disease (COPD), a progressive lung condition affecting millions of people, for up to $230 million.

Read More »

Biogen Faces Biggest One-Day Drop

In what feels a bit like a self-fulfilling prophecy, two analyst firms downgraded Biogen, causing the stock to drop.

Read More »

Crippled Bay Area Pharma Threshold Rockets on Reverse Merger Deal With Molecular Templates

Shares of Threshold Pharmaceuticals shot up more than 43 percent this morning after the company announced it was merging with Austin, Texas-based Molecular Templates Inc. and receiving an infusion of millions of dollars in financing.

Read More »

FDA Deals Another Blow to AstraZeneca’s Blood Drug

The U.S. Food and Drug Administration gave AstraZeneca’s New Drug Application for ZS-9 (sodium zirconium cyclosiliate) a Complete Response Letter (CRL) — again. The drug was being developed for hyperkalemia by ZS Pharma, a wholly owned subsidiary of AstraZeneca.

Read More »

Get thesis – completely unique job

Get thesis – completely unique job It takes much time to check out the certain matter and find out the needful results. Study paper requirements plenty of expertise to make a good one. This write is creating within the last season of examine and yes it demonstrates all your expertise and abilities.

Read More »

PTC to buy pricey Duchenne drug, signals price change

PTC Therapeutics Inc. said on Thursday it would buy Marathon Pharmaceuticals LLC’s recently approved Duchenne muscular dystrophy drug, Emflaza, and promised to re-examine the hefty U.S. price tag on the treatment.

Read More »

Not A Term Paper Mill!

★Edu★ Your Optimal Success Guide For Research Paper Writing The land of the rising sun has given rise to so many technology related developments that it is really next to impossible to keep pace with. The rates charged should be reasonable in that they reflect the quality of papers.

Read More »

IBM to integrate MedyMatch technology to help spot brain bleeding

Israel’s MedyMatch Technology said on Thursday IBM Watson Health would integrate MedyMatch’s technology into its offerings to imaging experts in hospitals to help doctors identify intracranial bleeding from head trauma and stroke.

Read More »

Major Reorganization to Hit the NIH, Deep Cuts to Affect Thousands Under Trump Budget Plan

Federal spending on health and human services takes a major blow under the first federal spending plan proposed by President Donald Trump.

Read More »

European Approval for Label Extension of Cinryze

The European Commission approved a label extension for three new indications for Shire’s Cinryze, broadening its use to children with hereditary angioedema.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom